AUROPHARMA - Eying for a big move on the upside?TF: 144 minutes
CMP: 1155
Details are explained well in the chart.. be it counts or price action breakout levels..
The scripts seems to be eying for the 3rd (3 of 3) wave up.. Stop below 1130
Disclaimer: I am not a SEBI registered Analyst and this is not a trading advise. Views are personal and
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
59.90 INR
34.86 B INR
317.24 B INR
274.99 M
About AUROBINDO PHARMA LTD
Sector
Industry
CEO
Kambam Nithyananda Reddy
Website
Headquarters
Hyderabad
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFTS8
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Related stocks
A bigger correction round the cornerAuropharma CMP 1155
Fibs - the retracement cannot go past 38.2% if weakness. Long shadows around the fib confluence zone is telling this is a supply zone.
Elliott - this is the C wave whose minimum tgt is 723
*RSI - See how the price failed even after taking bull support. Its an indication of
Aurobindo Pharma Limited (INE406A01037)I'm not a SEBI REGISTERED ANYLISIS
just for learning purpose
above the blue line close in D chart candle i will buy and put strictly SL to below red line...once candle close below Red line in D chart...i will close the Trade...
target check the chart
educational purpose only
oits simple ORB
AuropharmaDaily time frame shows price is testing trend line resistance, and lower time frame shows price consolidation in the form of symmetrical triangle.
Buy above 1210 with the stop loss of 1200 for the targets 1222, 1234, 1248 and 1264.
Sell below 1178 with the stop loss of 1188 for the targets 1166, 115
Short AurobindopharmaAnalysis of the Aurobindo Pharma Chart
From the chart you've shared, here are the key technical observations and strategy recommendations:
🔍 Chart Observations:
Descending Channel:
Aurobindo Pharma is clearly trading within a downward sloping channel (white parallel lines).
Current price: ₹1,159.
Bullish Projection for Aurobindo Pharma: Technical AnalysisKey Zones:
Bullish Order Block (OB): Found below at ₹1,146.30 (indicates strong demand area for price to rebound).
Bullish FVG (Fair Value Gap): This suggests there's liquidity and demand at the current levels, supporting a potential upward move.
Reasoning for Bullish Projection:
Spring
High conviction / value buy stock pick - AUROPHARMACheck this stock which has made an all time low and high chances that it makes a "V" shaped recovery.
> Taking support at last years support or breakout level
> High chances that it reverses from this point.
> Volume dried up badly in last few months / days.
> Very high suspicion based analysis and
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AUROPHARMA is 1,152.00 INR — it has increased by 1.23% in the past 24 hours. Watch AUROBINDO PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AUROBINDO PHARMA LTD stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has fallen by −4.16% compared to the previous week, the month change is a −0.21% fall, over the last year AUROBINDO PHARMA LTD has showed a −15.29% decrease.
We've gathered analysts' opinions on AUROBINDO PHARMA LTD future price: according to them, AUROPHARMA price has a max estimate of 1,640.00 INR and a min estimate of 1,010.00 INR. Watch AUROPHARMA chart and read a more detailed AUROBINDO PHARMA LTD stock forecast: see what analysts think of AUROBINDO PHARMA LTD and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 13, 2024 with the price of 1,592.00 INR, and its all-time low was 4.60 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 2.03% volatile and has beta coefficient of 1.01. Track AUROBINDO PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is AUROBINDO PHARMA LTD there?
Today AUROBINDO PHARMA LTD has the market capitalization of 661.42 B, it has decreased by −0.89% over the last week.
Yes, you can track AUROBINDO PHARMA LTD financials in yearly and quarterly reports right on TradingView.
AUROBINDO PHARMA LTD is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 15.56 INR per share, whereas the estimation was 17.57 INR resulting in a −11.44% surprise. The estimated earnings for the next quarter are 16.68 INR per share. See more details about AUROBINDO PHARMA LTD earnings.
AUROBINDO PHARMA LTD revenue for the last quarter amounts to 83.82 B INR, despite the estimated figure of 82.77 B INR. In the next quarter, revenue is expected to reach 82.19 B INR.
AUROPHARMA net income for the last quarter is 9.03 B INR, while the quarter before that showed 8.46 B INR of net income which accounts for 6.82% change. Track more AUROBINDO PHARMA LTD financial stats to get the full picture.
AUROBINDO PHARMA LTD dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.41% and 8.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA LTD EBITDA is 66.05 B INR, and current EBITDA margin is 20.82%. See more stats in AUROBINDO PHARMA LTD financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA LTD stock shows the buy signal. See more of AUROBINDO PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.